drugset / Trial / NCT07607275

Effect of the Traditional Chinese Medicine Yufeng Ningxin in Patients With Hypertension

NCT07607275 ↗

Phase 4 Recruiting 350 enrolled Beijing Anzhen Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Yufeng Ningxin, a traditional Chinese medicine, has demonstrated potential antihypertensive effects in animal studies and small clinical trials, but has not yet been rigorously evaluated in large randomized clinical trials. Here, the investigators conducted a double-blind, randomized controlled trial to assess the efficacy and safety of Yufeng Ningxin tablets in patients with hypertension.

Timeline

Start
2026-05-15
Primary completion
2027-12-01
Completion
2028-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Yufeng Ningxin Traditional medicine (herbal / TCM) 1.4 g —